Effectively Screening for Coronary Artery Disease in Patients Undergoing Orthotopic Liver Transplant Evaluation

Table 1

Clinical characteristics of our entire study cohort.

Age, years	56 ± 7.72
Male, (%)	92 (69.7)
Caucasian, (%)	117 (88.6)
African American, (%)	8 (6.1)
Hepatitis C cirrhosis, (%)	56 (42.4)
Nonalcoholic steatohepatitis, (%)	33 (25)
Alcohol cirrhosis, (%)	21 (15.9)
Model of end-stage liver disease	16.1 ± 5.94
Hypertension, (%)	49 (37.1)
Diabetes mellitus, (%)	45 (34.1)
Tobacco abuse, (%)	47 (35.6)
Hyperlipidemia, (%)	18 (13.6)
Obese, (%)	36 (27.3)
Family history of premature heart disease, (%)	28 (21.2)
Alcohol abuse, (%)	27 (20.4)
No coronary risk factors, (%)	37 (27.2)
One coronary risk factor, (%)	43 (31.6)
Two or more coronary risk factors, (%)	56 (41.2)
Serum creatinine	1.04 ± 0.62
INR	1.57 ± 0.44
Platelet count	83.85 ± 43.16

Values are shown as mean ± standard deviation.